UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 13D/13G Filings for Molecular Partners AG (MOLN)

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 13D and 13G filings for Molecular Partners AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-07-17
4:06 pm
Purchase		 2024-09-30 13G Molecular Partners AG
MOLN		 UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2,144,607
5.800%		 2,144,607increase
(New Position)		 Filing